Transcription factors and age-related decline in apolipoprotein A-I expression

Journal of Lipid Research

Volumn 40, Issue 9, 1999, Pages 1709-1718

  Nakamura, Takaaki ^a,b   Fox Robichaud, Alison ^a   Kikkawa, Ryuichi ^a,b   Kashiwagi, Astunori ^a,b   Kojima, Hideto ^a,b   Fujimiya, Mineko ^a,b   Wong, Norman C W ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Aging; ARP 1; Atherosclerosis; Cholesterol; HDL; HNF 3; HNF 4; Lipoprotein

Indexed keywords

APOLIPOPROTEIN A; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN; TRANSCRIPTION FACTOR;

AGING; ANIMAL CELL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BINDING AFFINITY; BINDING SITE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE ANALYSIS;

EID: 0032879908     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Reichl, D., and N. E. Miller. 1986 The anatomy and physiology of reverse cholesterol transport. Clin. Sci. 70: 221-231.
2. Rothblat, G. H., M. Bamberger, and M. C. Phillips. 1986. Reverse cholesterol transport. Methods Enzymol. 129: 628-644.
3. Hostmark, A. T., A. Osland., S. Simonsen, and K. Levorstad. 1990. Lipoprotein-related coronary risk factors in patients with angiographically defined coronary artery disease: relation to number of stenosed arteries. J. Intern. Med. 228: 317-321.
4. Phillips, N. R., D. Waters, and R. J. Havel. 1993. Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events. Circulation. 88: 2762-2770.
5. Noma, A., T. Yokosuka, and K. Kitamura. 1983. Plasma lipids and apolipoproteins as discriminators for presence and severity of angiographically defined coronary artery disease. Atherosclerosis. 49: 1-7.
6. Ford, E. S., R. S. Cooper, B. Simmons, and A. J. Castaner. 1990. Serum lipids, lipoproteins and apolipoproteins in black patients with angiographically defined coronary artery disease. Clin. Epidemiol. 43: 425-432.
7. Veress, A. I., J. F. Cornhill, E. E. Herderick, and J. D. Thomas. 1998. Age-related development of atherosclerotic plaque stress: a population-based finite-element analysis. Coron. Artery. Dis. 9: 13-19.
8. Green, M. S., G. Heiss, B. M. Rifkind, G. R. Cooper, O. D. Williams, and H. A. Tyroler. 1985. The ratio of plasma high-density lipoprotein cholesterol to total and low-density lipoprotein cholesterol: age-related changes and race and sex differences in selected North American populations. The Lipid Research Clinics Program Prevalence Study. Circulation. 72: 93-104.
9. Beaglehole, R., D. C. Trost, I. Tamir, P. Kwiterovich, C. J. Glueck, W. Insull, and B. Christensen. 1980. Plasma high-density lipoprotein cholesterol in children and young adults. The lipid research clinical program prevalence study. Circulation. 62: 83-92.
10. Hall, G. P., T. G. Redgrave, and G. C. T. Yeoh. 1995. The ontogeny of apolipoprotein expression in rat liver mRNA levels in developing liver and cultured fetal rat liver. Eur. J. Biochem. 228: 332-336.
11. Haddad, I. A., J. M. Ordovas, T. Fitzpatrick, and S. K. Karathanasis. 1986. Linkage, evolution, and expression of the rat apolipoprotein A-I, CIII and A-IV genes. J. Biol. Chem. 261: 13268-13277.
12. Elshourbagy, N. A., M. S. Boguski, W. S. L. Liao, L. S. Jefferson, J. I. Gordon, and J. M. Taylor. 1985. Expression of rat apolipoprotein A-IV and A-I genes: induction during development and in response to glucocorticoids and insulin. Proc. Natl. Acad. Sci. USA. 82: 8242-8246.
13. Chan, J., H. Nakabayashi, and N. C. W. Wong. 1993. HNF-4 increases activity of rat apo AI gene. Nucleic Acids Res. 21: 1205-1211.
14. Taylor, A. H., P. Wishart, D. E. Lawless, J. Raymond, N. C. W. Wong. 1996. Identification of functional positive and negative thyroid hormone-responsive elements in the rat apolipoprotein AI promoter. Biochemistry. 35: 8281-8288.
15. Romney, J. S., J. Chan, F. E. Carr, and N. C. W. Wong. 1992. Identification of thyroid hormone-responsive messenger RNA spot 11 as apolipoprotein-AI messenger RNA and effects of the hormone on the promoter. Mol. Endocrinol. 92: 943-950.
16. Koji, M., H. Bassyouni, A. H. Taylor, and N. C. W. Wong. 1997. Hepatocyte nuclear factor 4 inhibits the activity of site A from the rat apolipoprotein AI gene. Biochemistry. 36: 301-306.
17. Taylor, A. H., J. Raymond, J. M. Dionne, J. Romney, J. Chan, D. E. Lawless, I. E. Wanke, and N. C. W. Wong. 1996. Glucocorticoid increases rat apolipoprotein A-I promoter activity. J. Lipid. Res. 37: 2232-2242.
18. Malik, V. S., and E. P. Lillehoj. 1994. Antibody Techniques. Academic Press, San Diego, CA. 273-289.
19. Mariash, C. N., and S. Seelig. 1982. A rapid, inexpensive, quantitative technique for the analysis of two-dimensional electrophoreto gram. Anal. Biochem. 121: 388-394.
20. Jump, D. B., P. Narayan, and H. C. Towle. 1984. Rapid effects of thyroid hormone on hepatic gene expression. J. Biol. Chem. 259: 2789-2787.
21. Sambrooke, J., E. F. Fritch, and T. Maniatis. 1989. Molecular cloning. A Laboratory Manual. 2nd edition. Cold Spring Harbor Laboratory Press, Plainview, NY. 7.37-7.52.
22. Marzluff, W. F., and R. C. C. Huang. 1984. Transcription of RNA in isolated nuclei. In Transcription and Translation - a Practical Approach. B. D. Hames and S. J. Higgins, editors. IRL Press, Oxford, UK. 92-93.
23. Skettering, G., E. Gjernes, and H. Prydz. 1989. Regulation of lecithin:cholesterol acyltransferase by TGF-β and interleukin-6. Biochim. Biophys. Acta. 1255: 267-272.
24. Siebert, P. D., and J. W. Larrick. 1992. Competitive PCR. Nature. 358: 557-558.
25. Bolton, M. C., J. Dudhia, and M. T. Bayliss. 1996. Quantification of aggrecan and link-protein mRNA in human articular cartilage of different ages by competitive reverse transcriptase-PCR. Biochem. J. 319: 489-498.
26. Lai, E., V. R. Prezioso, W. Tao, W. S. Chen, and J. E. Darnell, Jr. 1991. Hepatocyte nuclear factor 3a belongs to a gene family in mammals that is homologous to the Drosophilia homeotic gene fork head. Genes & Dev. 5: 416-427.
27. Nakabayashi, H., K. Watanabe, A. Saito, A. Otsuru, K. Sawadaishi, and T. Tamaoki. 1989. Transcriptional regulation of alpha-fetoprotein expression by dexamethasone in human hepatoma cells. J. Biol. Chem. 264: 266-271.
28. Nakabayashi, H., T. Hashimoto, Y. Miyao, K. K. Tjong, J. Chan, and T. Tamaoki. 1991. A positive dependent silencer plays a major role in repressing alpha fetoprotein expression in human hepatoma. Mol. Cell. Biol. 11: 5885-5893.
29. Graham, F. L., and A. J. van der Eb. 1973. A new technique for assay of infectivity of human adenovirus 5 DNA. Virology. 52: 456-467.
30. Ladias, J. A. A., and S. K. Karathanasis. 1991. Regulation of the apolipoprotein AI gene by ARP-1 a novel member of the steroid receptor superfamily. Science. 251: 561-565.
31. Herbomel, P., B. Bourachot, and M. Yaniv. 1984. Two distinct enhancers with different cell specificites coexist in the regulatory region of polyoma. Cell. 39: 653-662.
32. Widom, R. L., J. A. A. Ladias, S. Kouidou, and S. K. Karathanasis. 1991. Synergistic interactions between transcription and factors. Mol. Cell. Endocrinol. 11: 677-687.
33. Koji, M., W.Yoshinaru, N. Takaaki, and N. C. W. Wong. 1998. Effects of glucose and insulin on rat apolipoprotein AI gene expression. J. Biol. Chem. 273: 18959-18965.
34. Harnish, D. C., S. Malik, and S. K. Karathanasis. 1994. Activation of apolipoprotein AI gene transcription by the liver-enriched factor HNF-3. J. Biol. Chem. 269: 28220-28226.
35. Pani, L., X. B. Quian, D. Clevidence, and R. H. Costa. 1992. The restricted promoter activity of the liver transcription factor hepato3 cyte nuclear factor 3 beta involves a cell-specific factor and positive autoactivation. Mol. Cell. Biol. 12: 552-562.
36. Harnish, D. C., S. Malik, E. Kilbourne, R. Costa, S. K. Karathanasis. 1996. Control of apolipoprotein AI gene expression through synergistic interactions between hepatocyte nuclear factor 3 and 4. J. Biol. Chem. 271: 13621-13628.
37. Nasrin, N., L. Ercolani, M. Denaro, X. F. Kong, and M. Alexander. 1990. An insulin response element in the glyceraldehyde-3-phosphate dehydrogenase gene binds a nuclear protein induced by insulin in cultured cells and by nutritional manipulations in vivo. Proc. Natl. Acad. Sci. USA. 87: 5273-5277.
38. Iphigenia, T., and V. I. Zannis. 1996. Binding specificity and modulation of the apoA-1 promoter activity by homo-and heterodimers of nuclear receptors. J. Biol. Chem. 271: 8402-8415.
39. Duncan, S. A., M. A. Navas, and M. Stoffel. 1998. Regulation of a transcription factor network required for differential and metabolism. Science. 281: 692-695.
40. Nolten, L. I., P. H. Steenbergh, and J. S. Sussenbach. 1996. The hepatocyte nuclear factor-3β stimulates the transcription of the human insulin-like growth factor I gene in a direct and indirect manner. J. Biol. Chem. 271: 31846-31854.
41. Pani, L., D. G. Overdier, A. Porcella, X. Qian, and R. H. Costa. 1992. Hepatocyte nuclear factor 3 beta contains two transcriptional activation domains, one of which is novel and conserved with the Drosophilia fork head protein. Mol. Cell. Biol. 12: 3723-3732.
42. Qian, X., and R. H. Costa. 1995. Analysis of hepatocyte nuclear factor-3β protein domains required for transcriptional activation and nuclear targeting. Nucleic Acids Res. 23: 1184-1191.
43. Kennelly, P. J., and E. G. Krebs. 1991. Consensus sequences as substrate specificity determinants for protein kinases and protein phosphatases. J. Biol. Chem. 266: 15555-15558.
44. Ingraham, H. A., S. E. Flynn, J. W. Voss, V. R. Albert, and M. G. Rosenfeld. 1990. The POU specific domain of Pit-1 is essential for sequence-specific, high affinity DNA binding and DNA dependent Pit-Pit-1 interaction. Cell. 61: 1021-1033.
45. Costa, R. H., and D. R. Grayson. 1991. Site-directed mutagenesis of hepatocyte nuclear factor (HNF) binding sites in the mouse transthyretin (TTR) promoter reveal synergistic interactions with its enhancer region. Nucleic Acids Res. 19: 4139-4145.
46. Samadani, U., X. Qian, and R. H. Costa. 1996. Identification of a transthyretin enhancer site that selectively binds the hepatocyte nuclear factor-3β isoform. Gene Expr. 6: 23-33.
47. Southwell, B. R., W. Duan, G. F. Tu, and G. Schreiber. 1991. Ontogenesis of transthyretin gene expression in chicken choroid plexus and liver. Comp. Biochem. Physiol. B: Comp. Biochem. 100: 329-338.
48. Westermark, P., K. Sletten, and K. H. Johnson. 1996. Aging and amyloid fibrillogenesis; lessons from apolipoprotein AI, transthyretin and islet amyloid polypeptide. Ciba Found. Symp. 199: 205-218.
49. Unterman, T. G., A. Fareeduddin, M. A. Harris, R. H. Costa, and R. G. Lacson. 1994. Hepatocyte nuclear factor-3 (HNF-3) binds to the insulin response sequence in the IGF binding protein-1 (IGFBP-1) promoter and enhances promoter function. Biochem. Biophys. Res. Commun. 203: 1835-1841.
50. Hogg, J., D. J. Hill, and V. K. M. Han. 1994. The ontogeny of insulin-like growth factor (IGF) and IGF-binding protein gene expression in the rat pancreas. J. Mol. Endocrinol. 13: 49-58.
51. D'Agostino, J., J. B. Field, and M. L. Frazier. 1985. Ontogeny of immunoreactive insulin in the fetal bovine pancreas. Endocrinology. 116: 1108-1116.
52. Staels, B., A. van Tol, L. Chan, and J. Auwerx. 1991. Variable effects of different corticosteroids on plasma lipids, apolipoproteins, and hepatic apolipoprotein mRNA levels in rats. Arterioscler. Thromb. 11: 760-769.